Evidence map›Paper›PMID 40153522›Full record

ArticleInternational journal of cancer2025

Screening outcomes at second FIT screening in individuals with a first time negative FIT-result or low-risk adenomas: Results from a nationwide FIT screening program.

Pernille Thordal Larsen, Susanne Fogh Jørgensen, Morten Rasmussen, Berit Andersen, Sisse Helle Njor

Abstract read
In one paragraph

Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pernille Thordal LarsenDepartment of Public Health Programmes, Randers Regional Hospital, UNICCA-University Research Clinic for Cancer Screening, Randers, Denmark.ORCID 0000-0002-2040-6142
Susanne Fogh JørgensenResearch Unit for Screening and Epidemiology, Department of Biochemistry and Immunology, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.ORCID 0000-0003-4534-0351
Morten RasmussenDigestive Disease Center, Bispebjerg Hospital, Copenhagen, Denmark.
Berit AndersenDepartment of Public Health Programmes, Randers Regional Hospital, UNICCA-University Research Clinic for Cancer Screening, Randers, Denmark.
Sisse Helle NjorDepartment of Clinical Medicine, Aarhus University Faculty of Health Sciences, Aarhus, Denmark.

Funding

Aage og Johanne Louis-Hansens Fond J.nr. 20-2B-6191Harboefonden 19243Helsefonden 20-B-0136Kræftens Bekæmpelse R269-A15801
6 · The paper itself

Abstract

In Denmark, participants in faecal immunochemical test (FIT) screening with low-risk adenomas are recommended a return to biennial FIT-screening. However, they participate less than the FIT-negative group (FIT

Indexed as

AdenomaColorectal NeoplasmsEarly Detection of CancerOccult BloodAdultAgedCohort StudiesColonoscopyDenmarkFemaleHumansIncidenceMaleMass ScreeningMiddle Agedcolorectal cancerFaecal immunochemical testlow‐risk adenomasscreening

Identifiers

PMID40153522
PMCPMC12178094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.